Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model

Table 1

Serum levels of FSH, AMH, and E2 determined by ELISA at different CTX posttreatment intervals in three groups (blank control group, saline treatment group, and CTX treatment group). Data were expressed as means ± SD ().

	0 weeks	1 week	2 weeks	3 weeks
FSH (IU/L)
Blank control	12.559 ± 1.485	12.294 ± 1.096	12.131 ± 0.834	13.294 ± 0.334
Saline control	10.621 ± 0.987	12.303 ± 1.292	13.690 ± 0.941	12.780 ± 1.239
CTX treatment	12.661 ± 0.404	14.401 ± 0.946	15.467 ± 0.782	18.164 ± 1.660
E2 (ng/L)
Blank control	52.146 ± 12.187	61.213 ± 4.385	53.824 ± 4.080	52.349 ± 10.963
Saline control	52.532 ± 3.097	55.330 ± 4.087	52.601 ± 9.040	51.927 ± 4.936
CTX treatment	49.284 ± 5.980	40.298 ± 7.885	38.095 ± 4.475	35.356 ± 4.567
AMH (pg/mL)
Blank control	166.288 ± 11.144	152.035 ± 9.665	174.385 ± 14.816	188.845 ± 21.469
Saline control	176.817 ± 15.977	165.875 ± 12.584	161.025 ± 13.914	174.635 ± 18.181
CTX treatment	180.490 ± 13.310	129.340 ± 14.390	153.680 ± 17.830	139.420 ± 7.700